Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Kamal Dua and Anand Krishnan.
Kamal Dua
Connection Strength
1.046
Anand Krishnan
  1. A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnostics. Chem Biol Interact. 2021 Aug 01; 344:109497.
    View in: PubMed
    Score: 0.473
  2. In vitro Dissolution Profile at Different Biological pH Conditions of Hydroxychloroquine Sulfate Tablets Is Available for the Treatment of COVID-19. Front Mol Biosci. 2020; 7:613393.
    View in: PubMed
    Score: 0.231
  3. Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis. Med Hypotheses. 2020 Nov; 144:110254.
    View in: PubMed
    Score: 0.226
  4. Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio-renal damage in COVID-19 infection. Drug Dev Res. 2021 09; 82(6):784-788.
    View in: PubMed
    Score: 0.058
  5. An overview of vaccine development for COVID-19. Ther Deliv. 2021 03; 12(3):235-244.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.